Top 100 Contractors in PSC AN: Health R&D Services, FY2022

Parent companies by net contract obligations Oct 1, 2021 – Sep 30, 2022 Code page on GovTribe

The top 10 won 37% of FY2022 PSC AN contract dollars

Ranking facts

Contract obligations
$4,690,704,477 Net of deobligations, by contracts coded PSC AN or a code under it
Contractors
894 Parent companies with an obligation
Largest contractor
Leidos Holdings, Inc. $570 million, 11.1% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $569,650,544
Rank history: #1 in FY2021, #2 in FY2023, #3 in FY2024 and #1 in FY2025; unchanged since FY2021.
2 $292,728,744
Rank history: not on the FY2021 list, #8 in FY2023 and not on the FY2024–FY2025 lists; new.
3
Modernatx Inc.
$272,246,352
Rank history: #2 in FY2021, #29 in FY2023 and not on the FY2024–FY2025 lists; down 1 since FY2021.
4 $134,641,073
Rank history: #5 in FY2021, #7 in FY2023, #4 in FY2024 and #2 in FY2025; up 1 since FY2021.
5 $125,948,978
Rank history: #8 in FY2021, #19 in FY2023, #12 in FY2024 and #7 in FY2025; up 3 since FY2021.
6 $119,888,969
Rank history: #3 in FY2021 and not on the FY2023–FY2025 lists; down 3 since FY2021.
7 $107,179,259
Rank history: #6 in FY2021, #16 in FY2023, #8 in FY2024 and #6 in FY2025; down 1 since FY2021.
8 $97,585,628
Rank history: not on the FY2021 list, #42 in FY2023 and not on the FY2024–FY2025 lists; new.
9 $91,458,423
Rank history: #11 in FY2021, #22 in FY2023, #16 in FY2024 and #32 in FY2025; up 2 since FY2021.
10 $87,000,000
Rank history: not on the FY2021 list, #26 in FY2023, #13 in FY2024 and #100 in FY2025; new.
11 $82,182,000
Rank history: #72 in FY2021 and not on the FY2023–FY2025 lists; up 61 since FY2021.
12 $79,410,899
Rank history: #46 in FY2021, #67 in FY2023 and not on the FY2024–FY2025 lists; up 34 since FY2021.
13 $75,243,268
Rank history: #14 in FY2021, #21 in FY2023, #17 in FY2024 and #18 in FY2025; up 1 since FY2021.
14 $74,918,565
Rank history: #9 in FY2021, #3 in FY2023, #15 in FY2024 and #10 in FY2025; down 5 since FY2021.
15 $72,764,234
Rank history: #60 in FY2021, #9 in FY2023 and not on the FY2024–FY2025 lists; up 45 since FY2021.
16 $66,997,308
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
17
Arcturus Therapeutics Inc.
$63,239,784
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
18 $55,000,000
Rank history: not on the FY2021 list, #23 in FY2023 and not on the FY2024–FY2025 lists; new.
19 $53,661,788
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
20 $45,323,792
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
21 $42,011,776
Rank history: #21 in FY2021, #31 in FY2023, #22 in FY2024 and #20 in FY2025; unchanged since FY2021.
22 $40,944,824
Rank history: #10 in FY2021, #40 in FY2023, #21 in FY2024 and not on the FY2025 list; down 12 since FY2021.
23 $40,493,398
Rank history: #19 in FY2021 and not on the FY2023–FY2025 lists; down 4 since FY2021.
24 $39,027,039
Rank history: #76 in FY2021, #20 in FY2023, #29 in FY2024 and #16 in FY2025; up 52 since FY2021.
25 $37,512,793
Rank history: #27 in FY2021, not on the FY2023 list, #53 in FY2024 and not on the FY2025 list; up 2 since FY2021.
26 $33,831,291
Rank history: #20 in FY2021, #33 in FY2023, #20 in FY2024 and #17 in FY2025; down 6 since FY2021.
27 $33,713,145
Rank history: #23 in FY2021, #39 in FY2023, #31 in FY2024 and #49 in FY2025; down 4 since FY2021.
28 $30,954,000
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
29 $30,739,391
Rank history: not on the FY2021 list, not on the FY2023–FY2024 lists and #45 in FY2025; up 76 since FY2021.
30 $30,340,516
Rank history: #49 in FY2021, #32 in FY2023, #10 in FY2024 and #8 in FY2025; up 19 since FY2021.
31
Seqirus USA Inc. Through Seqirus Inc.
$30,129,938
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
32 $29,432,278
Rank history: #7 in FY2021, #12 in FY2023, #11 in FY2024 and #13 in FY2025; down 25 since FY2021.
33 $28,108,045
Rank history: not on the FY2021 list, #36 in FY2023, #99 in FY2024 and not on the FY2025 list; new.
34 $25,850,726
Rank history: #16 in FY2021, #46 in FY2023, #34 in FY2024 and not on the FY2025 list; down 18 since FY2021.
35 $25,574,012
Rank history: #31 in FY2021, #41 in FY2023, #28 in FY2024 and not on the FY2025 list; down 4 since FY2021.
36 $25,479,184
Rank history: #62 in FY2021 and not on the FY2023–FY2025 lists; up 26 since FY2021.
37
Icahn School of Medicine at Mount Sinai 2 awardees
$24,310,425
Rank history: #18 in FY2021, #28 in FY2023, #26 in FY2024 and #31 in FY2025; down 19 since FY2021.
38 $24,200,292
Rank history: #28 in FY2021, #35 in FY2023, #52 in FY2024 and not on the FY2025 list; down 10 since FY2021.
39 $23,551,078
Rank history: #43 in FY2021, #62 in FY2023, #68 in FY2024 and #94 in FY2025; up 4 since FY2021.
40 $23,511,010
Rank history: #22 in FY2021, #14 in FY2023 and not on the FY2024–FY2025 lists; down 18 since FY2021.
41 $23,242,447
Rank history: #30 in FY2021, #63 in FY2023 and not on the FY2024–FY2025 lists; down 11 since FY2021.
42 $23,202,432
Rank history: #15 in FY2021, #57 in FY2023, #25 in FY2024 and #29 in FY2025; down 27 since FY2021.
43 $22,956,325
Rank history: #34 in FY2021, #53 in FY2023 and not on the FY2024–FY2025 lists; down 9 since FY2021.
44
University of North Carolina at Chapel Hill 3 awardees
$22,898,166
Rank history: #67 in FY2021, #91 in FY2023 and not on the FY2024–FY2025 lists; up 23 since FY2021.
45 $22,453,062
Rank history: #51 in FY2021 and not on the FY2023–FY2025 lists; up 6 since FY2021.
46 $22,429,401
Rank history: #96 in FY2021 and not on the FY2023–FY2025 lists; up 50 since FY2021.
47 $22,424,287
Rank history: #79 in FY2021, #37 in FY2023 and not on the FY2024–FY2025 lists; up 32 since FY2021.
48
Glaxosmithkline LLC
$22,165,843
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
49 $21,790,270
Rank history: #35 in FY2021, #38 in FY2023 and not on the FY2024–FY2025 lists; down 14 since FY2021.
50 $21,022,064
Rank history: #24 in FY2021, #27 in FY2023 and not on the FY2024–FY2025 lists; down 26 since FY2021.
51 $20,427,081
Rank history: #38 in FY2021, #60 in FY2023, #40 in FY2024 and #35 in FY2025; down 13 since FY2021.
52 $19,752,988
Rank history: not on the FY2021 list, #18 in FY2023, #60 in FY2024 and not on the FY2025 list; up 75 since FY2021.
53 $19,477,571
Rank history: #48 in FY2021 and not on the FY2023–FY2025 lists; down 5 since FY2021.
54
Aptargroup Inc. Through CSP Technologies, Inc.
$19,267,896
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
55 $19,070,356
Rank history: not on the FY2021 list, #74 in FY2023, #58 in FY2024 and not on the FY2025 list; new.
56 $18,989,471
Rank history: #71 in FY2021, #76 in FY2023, #63 in FY2024 and not on the FY2025 list; up 15 since FY2021.
57 $18,316,658
Rank history: #50 in FY2021 and not on the FY2023–FY2025 lists; down 7 since FY2021.
58 $17,030,213
Rank history: #90 in FY2021 and not on the FY2023–FY2025 lists; up 32 since FY2021.
59 $16,501,108
Rank history: #36 in FY2021, #71 in FY2023, #61 in FY2024 and #64 in FY2025; down 23 since FY2021.
60 $16,478,775
Rank history: #26 in FY2021, #54 in FY2023, #33 in FY2024 and #14 in FY2025; down 34 since FY2021.
61 $15,093,150
Rank history: #40 in FY2021, #56 in FY2023, #74 in FY2024 and not on the FY2025 list; down 21 since FY2021.
62
University of Montana System Through University of Montana
$14,640,620
Rank history: #99 in FY2021, #83 in FY2023 and not on the FY2024–FY2025 lists; up 37 since FY2021.
63 $14,298,984
Rank history: #12 in FY2021, #59 in FY2023 and not on the FY2024–FY2025 lists; down 51 since FY2021.
64 $14,112,452
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 259 since FY2021.
65 $14,033,639
Rank history: not on the FY2021 list, not on the FY2023–FY2024 lists and #46 in FY2025; up 63 since FY2021.
66 $14,028,545
Rank history: #39 in FY2021, #34 in FY2023, #51 in FY2024 and #30 in FY2025; down 27 since FY2021.
67 $13,083,900
Rank history: #32 in FY2021, #55 in FY2023, #45 in FY2024 and #54 in FY2025; down 35 since FY2021.
68 $12,895,698
Rank history: not on the FY2021 list, not on the FY2023 list, #56 in FY2024 and not on the FY2025 list; up 126 since FY2021.
69 $12,384,833
Rank history: #80 in FY2021 and not on the FY2023–FY2025 lists; up 11 since FY2021.
70 $12,383,618
Rank history: #73 in FY2021 and not on the FY2023–FY2025 lists; up 3 since FY2021.
71
Charles River Laboratories International Inc. Through Charles River Laboratories, Inc.
$12,013,193
Rank history: #82 in FY2021, #82 in FY2023 and not on the FY2024–FY2025 lists; up 11 since FY2021.
72 $11,772,214
Rank history: #37 in FY2021, #25 in FY2023, #62 in FY2024 and not on the FY2025 list; down 35 since FY2021.
73 $11,772,087
Rank history: #47 in FY2021, #80 in FY2023 and not on the FY2024–FY2025 lists; down 26 since FY2021.
74 $11,608,030
Rank history: #85 in FY2021 and not on the FY2023–FY2025 lists; up 11 since FY2021.
75 $11,461,364
Rank history: not on the FY2021 list, not on the FY2023 list, #50 in FY2024 and not on the FY2025 list; up 92 since FY2021.
76 $10,877,462
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
77 $10,873,163
Rank history: #100 in FY2021, #73 in FY2023, #23 in FY2024 and #25 in FY2025; up 23 since FY2021.
78 $10,800,444
Rank history: #70 in FY2021, #92 in FY2023 and not on the FY2024–FY2025 lists; down 8 since FY2021.
79 $10,627,538
Rank history: not on the FY2021 list, #75 in FY2023, #55 in FY2024 and #75 in FY2025; up 30 since FY2021.
80 $10,464,717
Rank history: not on the FY2021 list, #69 in FY2023, #76 in FY2024 and #87 in FY2025; up 84 since FY2021.
81 $10,368,515
Rank history: #94 in FY2021, #87 in FY2023, #83 in FY2024 and #92 in FY2025; up 13 since FY2021.
82 $10,324,590
Rank history: #42 in FY2021, #81 in FY2023, #49 in FY2024 and #65 in FY2025; down 40 since FY2021.
83 $10,280,928
Rank history: #54 in FY2021, #72 in FY2023 and not on the FY2024–FY2025 lists; down 29 since FY2021.
84 $10,032,425
Rank history: #77 in FY2021 and not on the FY2023–FY2025 lists; down 7 since FY2021.
85
Deloitte Consulting LLP
$9,999,920
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
86 $9,832,866
Rank history: #63 in FY2021, #52 in FY2023 and not on the FY2024–FY2025 lists; down 23 since FY2021.
87 $9,733,621
Rank history: #44 in FY2021, #45 in FY2023, #91 in FY2024 and not on the FY2025 list; down 43 since FY2021.
88 $9,730,684
Rank history: #98 in FY2021 and not on the FY2023–FY2025 lists; up 10 since FY2021.
89
Icon Government and Public Health Solutions Inc.
$9,660,898
Rank history: not on the FY2021 list, #4 in FY2023 and not on the FY2024–FY2025 lists; new.
90 $9,562,863
Rank history: #95 in FY2021, #78 in FY2023, #57 in FY2024 and #82 in FY2025; up 5 since FY2021.
91 $8,974,110
Rank history: not on the FY2021 list, #90 in FY2023, #96 in FY2024 and not on the FY2025 list; up 75 since FY2021.
92 $8,944,500
Rank history: not on the FY2021 list, #93 in FY2023 and not on the FY2024–FY2025 lists; new.
93 $8,752,244
Rank history: #78 in FY2021 and not on the FY2023–FY2025 lists; down 15 since FY2021.
94 $8,642,658
Rank history: #58 in FY2021 and not on the FY2023–FY2025 lists; down 36 since FY2021.
95 $8,528,240
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
96
Compagnie Merieux Alliance 2 awardees, including Advanced Bioscience Laboratories, Inc.
$8,521,533
Rank history: #68 in FY2021 and not on the FY2023–FY2025 lists; down 28 since FY2021.
97 $8,376,295
Rank history: #59 in FY2021, #77 in FY2023, #71 in FY2024 and #61 in FY2025; down 38 since FY2021.
98 $8,173,033
Rank history: not on the FY2021 list, #30 in FY2023 and not on the FY2024–FY2025 lists; up 18 since FY2021.
99 $8,091,435
Rank history: #92 in FY2021 and not on the FY2023–FY2025 lists; down 7 since FY2021.
100 $8,079,970
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 1 since FY2021.
Show 75 more

100 of 894 contractors listed here. See the rest on GovTribe.

Rankings for the codes under PSC AN

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $5.14 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2022 ran Oct 1, 2021 – Sep 30, 2022. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2021. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2021 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 PSC AN contractors in FY2022?

1. Leidos Holdings, Inc. ($570M), 2. Amgen Inc. ($293M), 3. Modernatx Inc. ($272M), 4. Medical Technology Enterprise Consortium ($135M), 5. Westat, Inc. ($126M), 6. PPD Development LP ($120M), 7. The Mitre Corporation ($107M), 8. Mapp Biopharmaceutical, Inc. ($97.6M), 9. ABT Global LLC ($91.5M), 10. Phlow Corp. ($87M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work